CD8A and neoplasm: Compared to anti‐PD‐L1 treatment alone, monotreatment with bintrafusp alfa increased the tumor density and activity of CD8+ T cells, NK cells, neutrophils, and tumor associated dendritic cell and M1 macrophages.120, 135